URIEL PHARMACY, INC.

2549006UI9DPU4KRZV19

The entity

Country: United States
Legal address: C/O MARK S MCKIBBEN, N8464 STERMAN RD53120 EAST TROYUnited States (US-WI)
Head office: N8464 STERMAN RD53120 EAST TROYUnited States (US-WI)

LEI: 2549006UI9DPU4KRZV19
Registered: January 24, 2024 at 10:45 AM UTC
Last updated: January 24, 2025 at 01:30 PM UTC
Next renewal: January 24, 2025 at 10:45 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Corporation Section (Division of Corporate & Consumer Services, Department of Financial Institutions) (RA000642)
Identifier: U024591
Verified against: Corporation Section (Division of Corporate & Consumer Services, Department of Financial Institutions) (RA000642)
Verified as: U024591
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

REST: https://lei.online/v1/entities/2549006UI9DPU4KRZV19This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.